Intravenous Acetaminophen in the Emergency Department

Although intravenous acetaminophen has been marketed in over 80 countries since 2001, the product was only recently approved by the Food and Drug Administration, in November 2010. Much debate surrounds who should receive intravenous acetaminophen. A major limitation for use is increased cost compare...

Full description

Saved in:
Bibliographic Details
Published inJournal of emergency nursing Vol. 39; no. 1; pp. 92 - 96
Main Authors Kwiatkowski, Jennifer L., Walker, Pamela L.
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.01.2013
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Although intravenous acetaminophen has been marketed in over 80 countries since 2001, the product was only recently approved by the Food and Drug Administration, in November 2010. Much debate surrounds who should receive intravenous acetaminophen. A major limitation for use is increased cost compared with oral or rectal administration. However, potential pharmacokinetic advantages and a reduction in adverse effects compared with nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids have warranted further examination. The emergency department is one patient care area where the availability of an intravenous formulation is beneficial for urgent, short-term administration. Although there is limited American literature to support the use of intravenous acetaminophen, a few European studies in the emergency department raise the consideration for its use. Here, Kwiatkowski and Walker discuss the intravenous acetaminophen in the emergency department.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0099-1767
1527-2966
DOI:10.1016/j.jen.2012.08.005